Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT2B | Q92831 | 2/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.34 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.32 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.32 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.32 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15574020 | 0.92 | GRIN2D (0.34) | KAT2BMCL1HDAC8HDAC3HDAC1 | |
| SCHEMBL13615362 | 0.90 | IDO1 (0.33) | KAT2BMCL1HDAC8HDAC3HDAC1 | |
| SCHEMBL15572910 | 0.88 | HDAC1 (0.31) | KAT2BMCL1HDAC8HDAC3HDAC1 | |
| SCHEMBL13751664 | 0.88 | HDAC8 (0.36) | KAT2BMCL1HDAC8HDAC3HDAC1 | |
| SCHEMBL15786475 | 0.88 | PGK1 (0.39) | KAT2BMCL1HDAC8HDAC3HDAC1 | |
| SCHEMBL21527949 | 0.88 | ALDH1A1 (0.32) | KAT2BMCL1HDAC8HDAC3HDAC1 | |
| SCHEMBL20644675 | 0.86 | HDAC8 (0.34) | HDAC8HDAC3NCOR2 | |
| SCHEMBL13887515 | 0.85 | GRIN2D (0.43) | KAT2BHDAC8HDAC3HDAC1HDAC2 | |
| SCHEMBL13855830 | 0.85 | TSHR (0.38) | KAT2BMCL1HDAC8HDAC3HDAC1 | |
| SCHEMBL14270116 | 0.83 | IDO1 (0.37) | KAT2BMCL1HDAC8HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116589522-A | Oleanolic acid C28 glucose trimer derivative and application thereof | 昆明理工大学 | 2023-08-15 | — | — | CN | claimed |
| CN-121249189-A | Aromatic solid traditional Chinese painting pigment and preparation method thereof | 山东米娅文化用品有限公司 | 2026-01-02 | — | — | CN | disclosed |
| WO-2025076148-A1 | DIRECT AIR CAPTURE OF CARBON DIOXIDE WITH MOLECULAR POLYAMINES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-04-10 | — | — | WO | disclosed |
| CN-116284772-B | Bipyridine triazole covalent organic polymer and preparation method and application thereof | 四川大学 | 2024-02-27 | — | — | CN | disclosed |
| CN-116284772-B | Bipyridine triazole covalent organic polymer and preparation method and application thereof | 四川大学 | 2024-02-27 | — | — | CN | disclosed |
| CN-116589522-A | Oleanolic acid C28 glucose trimer derivative and application thereof | 昆明理工大学 | 2023-08-15 | — | — | CN | disclosed |
| CN-115521455-B | Preparation method of polytriazole polyether elastomer | 北京理工大学 | 2023-06-30 | — | — | CN | disclosed |
| CN-116284772-A | Bipyridine triazole covalent organic polymer and preparation method and application thereof | 四川大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-116284772-A | Bipyridine triazole covalent organic polymer and preparation method and application thereof | 四川大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-108341951-B | Dynamic polymer with hybrid cross-linked structure and application thereof | 厦门天策材料科技有限公司 | 2023-06-20 | — | — | CN | disclosed |
| US-20130101516-A1 | NANOPARTICLES AND NANOPARTICLE COMPOSITIONS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2013-04-25 | — | — | US | disclosed |
| US-20130101516-A1 | NANOPARTICLES AND NANOPARTICLE COMPOSITIONS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2013-04-25 | — | — | US | disclosed |
| WO-2011130114-A1 | NANOPARTICLES AND NANOPARTICLE COMPOSITIONS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2011-10-20 | — | — | WO | disclosed |
| US-20110065864-A1 | Method for Crosslinking by Thermal Huisgen Reaction, Crosslinkable Chromophoric Polymers, and Crosslinked Polymer Substances Having Stable Electro-Optical Properties | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2011-03-17 | — | — | US | disclosed |
| US-20090291989-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2009-11-26 | — | — | US | disclosed |
| US-20090291989-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2009-11-26 | — | — | US | disclosed |
| US-20090196829-A1 | MRI CONTRAST AGENTS AND RELATED METHODS OF USE | NORTHWESTERN UNIVERSITY (US) | 2009-08-06 | — | — | US | disclosed |
| US-20090196829-A1 | MRI CONTRAST AGENTS AND RELATED METHODS OF USE | NORTHWESTERN UNIVERSITY (US) | 2009-08-06 | — | — | US | disclosed |
| US-20090092980-A1 | miRNA PROCESSING INHIBITOR EFFICACY ASSAYS AND SUBSTANCES | ARENZ CHRISTOPH | 2009-04-09 | — | — | US | disclosed |
| US-20090092980-A1 | miRNA PROCESSING INHIBITOR EFFICACY ASSAYS AND SUBSTANCES | ARENZ CHRISTOPH | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090092980-A1 | miRNA PROCESSING INHIBITOR EFFICACY ASSAYS AND SUBSTANCES | AGO2, NUDT21, RNASE1 | KAT2B 2990/4885MCL1 367/4885HDAC8 1858/4885 |
| US-20130101516-A1 | NANOPARTICLES AND NANOPARTICLE COMPOSITIONS | MCM6, MPI, MSH2 | KAT2B 798/4885MCL1 11/4885HDAC8 1916/4885 |
| US-20090291989-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | TST, TREH, NFATC1 | KAT2B 2145/4885MCL1 1279/4885HDAC8 273/4885 |
| US-20090196829-A1 | MRI CONTRAST AGENTS AND RELATED METHODS OF USE | MAG, AQP4, LPXN | KAT2B 501/4885MCL1 2307/4885HDAC8 2265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.